Bladder cancer trials in Germany
38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
No phaseNot yet recruitingResearch participation
REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors
- Where
- Augsburg, Erlangen, Munich, Nuremberg
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- Ludwig-Maximilians - University of Munich
See details and how to joinNCT07762820Registry updated 2026-08-17
Phase 1/2RecruitingTrial-stage medicine
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Where
- Cologne, Duisburg, Erlangen, Mettmann, Nuertingen, Regensburg, Tuebingen
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- enGene, Inc.
See details and how to joinNCT04752722EU 2024-512900-20-00Registry updated 2026-08-07
Phase 2/3RecruitingTrial-stage medicine
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Berlin, Düsseldorf, Frankfurt, Hamburg, Hanover, Heidelberg, Herne, Jena, Kiel, Munich, Nuremberg, Nürtingen, Regensburg, Ulm
- Age
- 18 years and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762Registry updated 2026-07-29
Phase 2RecruitingTrial-stage medicine
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Berlin, Frankfurt am Main, Heidelberg
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797EU 2024-513578-23-00Registry updated 2026-07-27
Phase 3RecruitingTrial-stage medicine
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Where
- Bochum, Bonn, Dresden, Duisburg, Frankfurt am Main, Hamburg, Hanover, Herne, Magdeburg, Mannheim, Marburg, Mettmann, Münster, Nuremberg, Nürtingen, Regensburg, Rostock, Stuttgart, Tübingen, Ulm
- Age
- 18 years and over
- People
- 915 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07720284Registry updated 2026-07-22
No phaseRecruitingResearch participation
Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity
- Where
- Munich
- Age
- 18 years and over
- People
- 146
- Run by
- Ludwig-Maximilians - University of Munich
See details and how to joinNCT06806059Registry updated 2026-04-27
No phaseRecruitingResearch participation
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Tübingen
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305Registry updated 2026-03-05
No phaseRecruitingResearch participation
Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma
- Where
- Augsburg, Munich, Würzburg
- Age
- 18 years and over
- People
- 80
- Run by
- Comprehensive Cancer Center Munich (CCCM)
See details and how to joinNCT06657157Registry updated 2026-02-24
No phaseNot yet recruitingResearch participation
Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test
- Where
- Ulm
- Age
- 40 years and over
- People
- 1,475
- Run by
- Christian Bolenz
See details and how to joinNCT07307300Registry updated 2025-12-29
No phaseRecruitingResearch participation
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
- Where
- Erlangen
- Age
- 18 years and over
- People
- 200
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT04892849Registry updated 2025-09-17
No phaseRecruitingResearch participation
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Hamburg
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767Registry updated 2024-08-26
No phaseRecruitingTrial-stage medicine
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
- Where
- Erlangen
- Age
- 18 years and over
- People
- 1,000
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT05397262Registry updated 2024-05-09
No phaseRecruitingResearch participation
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
- Where
- Berlin
- Age
- 18 years and over
- People
- 649
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT06116019Registry updated 2023-11-03
All Bladder cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.